Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-20-002874

EXECUTIVE CHAIRMAN OF BOARD sold 37,829 shares at $5.19 ($196,333)

  • EXECUTIVE CHAIRMAN OF BOARD acquired 41,667 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Jaksch Frank L Jr · EXECUTIVE CHAIRMAN OF BOARD

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-10 Exercise or conversion : show line 1 in the form +41,667 $4.62 $192,502 262,168 D
2020-12-10 Sale : show line 2 in the form −37,829 $5.19 $196,333 224,339 D
Open-market sales · 37,829 sh · avg $5.19 · $196,333

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-10 Exercise or conversion : show line 3 in the form Employee Stock Options (right to buy) −41,667 0 D
Loading xslF345X03/form4-12112020_021211.xml…